Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Functional autoantibodies in patients with different forms of dementia.

Wallukat G, Prüss H, Müller J, Schimke I.

PLoS One. 2018 Mar 14;13(3):e0192778. doi: 10.1371/journal.pone.0192778. eCollection 2018.

2.

Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.

Robertson N, Rappas M, Doré AS, Brown J, Bottegoni G, Koglin M, Cansfield J, Jazayeri A, Cooke RM, Marshall FH.

Nature. 2018 Jan 3;553(7686):111-114. doi: 10.1038/nature25025.

PMID:
29300009
3.

Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.

Bussiere R, Lacampagne A, Reiken S, Liu X, Scheuerman V, Zalk R, Martin C, Checler F, Marks AR, Chami M.

J Biol Chem. 2017 Jun 16;292(24):10153-10168. doi: 10.1074/jbc.M116.743070. Epub 2017 May 5.

4.

Stress-Induced Alterations of Immune Profile in Animals Suffering by Tau Protein-Driven Neurodegeneration.

Novak P, Cente M, Kosikova N, Augustin T, Kvetnansky R, Novak M, Filipcik P.

Cell Mol Neurobiol. 2018 Jan;38(1):243-259. doi: 10.1007/s10571-017-0491-3. Epub 2017 Apr 12.

PMID:
28405903
5.

Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.

Yang T, Li S, Xu H, Walsh DM, Selkoe DJ.

J Neurosci. 2017 Jan 4;37(1):152-163. doi: 10.1523/JNEUROSCI.1698-16.2016.

6.

Activation of β2-adrenergic receptor promotes dendrite ramification and spine generation in APP/PS1 mice.

Chai GS, Wang YY, Zhu D, Yasheng A, Zhao P.

Neurosci Lett. 2017 Jan 1;636:158-164. doi: 10.1016/j.neulet.2016.11.022. Epub 2016 Nov 9.

PMID:
27838449
7.

Pharmacogenetics of healthy volunteers in Puerto Rico.

Claudio-Campos K, Orengo-Mercado C, Renta JY, Peguero M, García R, Hernández G, Corey S, Cadilla CL, Duconge J.

Drug Metab Pers Ther. 2015 Dec;30(4):239-49. doi: 10.1515/dmpt-2015-0021. Review.

8.

A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases.

Poppinga WJ, Muñoz-Llancao P, González-Billault C, Schmidt M.

Br J Pharmacol. 2014 Dec;171(24):5603-23. doi: 10.1111/bph.12882. Review.

9.

Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease.

Branca C, Wisely EV, Hartman LK, Caccamo A, Oddo S.

Neurobiol Aging. 2014 Dec;35(12):2726-2735. doi: 10.1016/j.neurobiolaging.2014.06.011. Epub 2014 Jun 16.

10.

Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?

Gibbs M.

Metab Brain Dis. 2015 Feb;30(1):345-52. doi: 10.1007/s11011-014-9563-y. Epub 2014 May 9. Review.

PMID:
24810634
11.

Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.

Wisely EV, Xiang YK, Oddo S.

Hum Mol Genet. 2014 Aug 1;23(15):4024-34. doi: 10.1093/hmg/ddu116. Epub 2014 Mar 13.

12.

Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.

Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A.

Biol Psychiatry. 2014 Feb 1;75(3):179-88. doi: 10.1016/j.biopsych.2013.05.024. Epub 2013 Jul 1.

PMID:
23827853
13.

The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.

Lương Kv, Nguyen LT.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):427-39. doi: 10.1177/1533317513488924. Epub 2013 May 20. Review.

PMID:
23689075
14.

β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.

Wang D, Fu Q, Zhou Y, Xu B, Shi Q, Igwe B, Matt L, Hell JW, Wisely EV, Oddo S, Xiang YK.

J Biol Chem. 2013 Apr 12;288(15):10298-307. doi: 10.1074/jbc.M112.415141. Epub 2013 Feb 19.

15.

Alzheimer's γ-secretase under arrestin.

Wolfe MS.

Nat Med. 2013 Jan;19(1):22-4. doi: 10.1038/nm.3053. No abstract available.

PMID:
23296004
16.

β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease.

Thathiah A, Horré K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S, De Strooper B.

Nat Med. 2013 Jan;19(1):43-9. doi: 10.1038/nm.3023. Epub 2012 Dec 2.

PMID:
23202293
17.

β2-adrenergic receptor and astrocyte glucose metabolism.

Dong JH, Chen X, Cui M, Yu X, Pang Q, Sun JP.

J Mol Neurosci. 2012 Oct;48(2):456-63. Epub 2012 Mar 8.

PMID:
22399228
18.

Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.

Karczewski P, Hempel P, Kunze R, Bimmler M.

Scand J Immunol. 2012 May;75(5):524-30. doi: 10.1111/j.1365-3083.2012.02684.x.

19.

Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons.

Wang D, Yuen EY, Zhou Y, Yan Z, Xiang YK.

J Biol Chem. 2011 Sep 9;286(36):31852-63. doi: 10.1074/jbc.M111.244335. Epub 2011 Jul 11.

20.

Supplemental Content

Loading ...
Support Center